Home›Stock Screener›Titan Biotech›Quarterly Results

Titan Biotech Quarterly Results

Latest Quarter Net Profit
₹7 Cr
QMar 2026
Quarterly Results

Titan Biotech quarterly results. In Mar 2026, Titan Biotech (TITANBIO) reported revenue ₹51 Cr and net profit ₹7 Cr — revenue +37.8% YoY. Check TITANBIO market capitalization to track the company's total market size over time.

TITANBIO Quarterly Results — Revenue, Profit & EPS Highlights

Titan Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review Titan Biotech price earnings to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹51 Cr in Mar 2026 (-16.4% vs Jun 2026, +37.8% vs Mar 2025)
  • Net Profit of ₹7 Cr in Mar 2026 (-36.4% vs Jun 2026, +75.0% vs Mar 2025)
  • EBITDA of ₹12 Cr in Mar 2026 (-14.3% vs Jun 2026)
  • Operating Margin of 20.0% in Mar 2026 (-1.0pp vs Jun 2026)
  • Earnings Per Share of ₹1.63 in Mar 2026 (-38.0% vs Jun 2026)

Titan Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

TITANBIO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 51 61 56 37 47 -16.4% 37.8%
Net Profit (₹ Cr) 7 11 8 4 7 - -
EBITDA (₹ Cr) 12 14 11 6 10 - -
EPS (₹) 1.63 2.63 9.40 4.90 8.30 - -
Operating Margin (%) 20.0% 21.0% 17.0% 13.0% 19.0% - -

TITANBIO Share Price Trend — 1-Year Movement Across Quarterly Results

Titan Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Titan Biotech share price screener.

Profitability Ratios

Profit Margin 13.7%
EBITDA Margin 23.5%
Operating Margin 20.0%
ROE (Annual) 15.4%

Balance Sheet Highlights

Total Assets ₹214 Cr
Total Equity ₹182 Cr
Current Assets ₹85 Cr
Current Liabilities ₹6 Cr

Cash Flow Analysis

Operating Cash Flow ₹30 Cr
Investing Cash Flow ₹-33 Cr
Financing Cash Flow ₹-2 Cr
Net Cash Flow ₹-4 Cr

Current Market Data

Current Price ₹383.20
Exchange BSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 37
Sept 2025 56
Jun 2026 61
Mar 2026 51

Net Profit Trend (₹ Cr)

Mar 2025 4
Sept 2025 8
Jun 2026 11
Mar 2026 7

Operating Margin Trend (%)

Mar 2025 13.0%
Sept 2025 17.0%
Jun 2026 21.0%
Mar 2026 20.0%

TITANBIO vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Titan Biotech latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Mar 2026 		₹149,017.59 Cr 1487.7 3,648 584 -21.7% - 16.0% 261.5
SRF
Mar 2026 		₹73,697.14 Cr 2460.0 4,557 582 -8.4% - 12.8% 125.3
Linde
Mar 2026 		₹53,281.32 Cr 6041.0 621 77 -11.5% - 12.4% 665.3
Coromandel Internat…
Mar 2026 		₹52,036.94 Cr 1801.4 6,068 115 -26.1% - 1.9% 379.2
Gujarat Fluorochemi…
Mar 2026 		₹50,280.54 Cr 4429.8 1,375 100 -14.1% - 7.3% 446.6
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores